Back to Search
Start Over
Preconditioned human dental pulp stem cells with cerium and yttrium oxide nanoparticles effectively ameliorate diabetic hyperglycemia while combatting hypoxia.
- Source :
-
Tissue & cell [Tissue Cell] 2021 Dec; Vol. 73, pp. 101661. Date of Electronic Publication: 2021 Oct 07. - Publication Year :
- 2021
-
Abstract
- The development of efficient insulin producing cells (IPC) induction system is fundamental for the regenerative clinical applications targeting Diabetes Mellitus. This study was set to generate IPC from human dental pulp stem cells (hDPSCs) capable of surviving under hypoxic conditions in vitro and in vivo.<br />Methods: hDPSCs were cultured in IPCs induction media augmented with Cerium or Yttrium oxide nanoparticles along with selected growth factors & cytokines. The generated IPC were subjected to hypoxic stress in vitro to evaluate the ability of the nanoparticles to combat hypoxia. Next, they were labelled and implanted into diabetic rats. Twenty eight days later, blood glucose and serum insulin levels, hepatic hexokinase and glucose-6-phosphate dehydrogenase activities were measured. Pancreatic vascular endothelial growth factor (VEGF), pancreatic duodenal homeobox1 (Pdx-1), hypoxia inducible factor 1 alpha (HIF-1α) and Caspase-3 genes expression level were evaluated.<br />Results: hDPSCs were successfully differentiated into IPCs after incubation with the inductive media enriched with nanoparticles. The generated IPCs released significant amounts of insulin in response to increasing glucose concentration both in vitro & in vivo. The generated IPCs showed up-regulation in the expression levels of anti-apoptotic genes in concomitant with down-regulation in the expression levels of hypoxic, and apoptotic genes. The in vivo study confirmed the homing of PKH-26-labeled cells in pancreas of treated groups. A significant up-regulation in the expression of pancreatic VEGF and PDX-1 genes associated with significant down-regulation in the expression of pancreatic HIF-1α and caspase-3 was evident.<br />Conclusion: The achieved results highlight the promising role of the Cerium & Yttrium oxide nanoparticles in promoting the generation of IPCs that have the ability to combat hypoxia and govern diabetes mellitus.<br /> (Copyright © 2021 Elsevier Ltd. All rights reserved.)
- Subjects :
- Animals
Blood Glucose metabolism
Caspase 3 genetics
Caspase 3 metabolism
Cell Hypoxia genetics
Cells, Cultured
Diabetes Mellitus, Experimental complications
Gene Expression Regulation drug effects
Humans
Hyperglycemia complications
Hypoxia-Inducible Factor 1, alpha Subunit metabolism
Insulin blood
Insulin metabolism
Male
Rats, Wistar
Stem Cells drug effects
Vascular Endothelial Growth Factor A metabolism
Rats
Cerium pharmacology
Dental Pulp cytology
Diabetes Mellitus, Experimental pathology
Hyperglycemia pathology
Nanoparticles chemistry
Stem Cells cytology
Yttrium pharmacology
Subjects
Details
- Language :
- English
- ISSN :
- 1532-3072
- Volume :
- 73
- Database :
- MEDLINE
- Journal :
- Tissue & cell
- Publication Type :
- Academic Journal
- Accession number :
- 34656024
- Full Text :
- https://doi.org/10.1016/j.tice.2021.101661